The market for Obstructive Sleep Apnea (OSA) products is currently approaching $3 billion worldwide. Market growth is predicted to be 16-19% per year globally due to demographic factors and growing awareness of the condition.
The current standard of treatment for patients is the Continuous Positive Airway Pressure (CPAP) machine. This device consists of an air pump and mask that the patient wears while sleeping. Even though the CPAP works well, the compliance rate of use for this treatment is less than 50% due to discomfort, noise, and other issues. The National Institutes of Health has stated that sleep apnea is a major public health problem and a replacement for CPAP is needed.
LinguaFlex’s LTR is implanted and designed to be comfortable, therefore addressing the lack of compliance as an issue in the successful treatment of OSA.